COVID-19

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Cyrano noses toward pivotal trial after midphase smell loss win

The biotech is preparing to take its treatment for persistent smell loss into phase 3 in the second half of the year.
Nick Paul Taylor Feb 17, 2026 10:15am
change direction new plan alter arrows move reprioritize

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

Feb 10, 2026 7:50am
FDA

FDA names Tracy Beth Høeg as acting head of drug center

Dec 4, 2025 4:03am
3D rendering of SARS-CoV-2 virus particles

Dynavax pays Vaxart $30M for oral COVID-19 vaccine program

Nov 6, 2025 5:50am
cartoon of man unplugging from outlet

Pfizer pulls the plug on 11 programs

Nov 4, 2025 2:40pm
Sketch of lungs

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am
More News

Abbott device growth offsets diagnostics sales slide in Q3

Oct 15, 2025 11:00am
Fierce Pharma

ACIP narrowly votes against COVID vaccine prescriptions

Sep 19, 2025 5:22pm
Fierce Pharma

RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation

Sep 4, 2025 3:51pm

NIH head says public distrust prompted mRNA vaccine rollback

Aug 12, 2025 2:08pm